About this trial
The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms:
* DaVinci®; * Hugo®.
The questions it aims to answer are:
Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable?
Participants will be invited to join one of these two experimental group:
1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.
Eligibility criteria
Qualifiers
patient aged between 18 and 90 years old;
patient with localized kidney tumor suitable for partial nephrectomy;
patient able to understand and sign the informed consent;
patient compliance with the follow-up program.
Disqualifiers
patient who do not fall within the inclusion age range;
patient not suitable for partial nephrectomy;
patient unable to understand and sign the informed consent;
patient unable to follow the monitoring program;
Trial design
Treatments tested in this trial
- DaVinci RAPN
- Hugo RAS RAPN